TS
PTLA

Twin Securities’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Twin Securities’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-529,626
Closed -$9.53M – 19
2020
Q2 		$9.53M Buy
+529,626
New +$7.37M 5.65% 4

Twin Securities's PTLA Position: Q3 2020 in Review

Twin Securities sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 529,626 shares — an estimated $9.53M sold.

Twin Securities first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $9.53M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Twin Securities reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Twin Securities sold 529,626 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9.53M.
  • Twin Securities first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Twin Securities's Portola Pharmaceuticals, Inc. position peaked at $9.53M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Twin Securities's 13F filing for Q3 2020, filed 16 Nov 2020.